Position in ABBV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,178,036,542
-$355,117,877 QoQ
Shares Held
5,416,509
-19.3% QoQ
Ownership
0.307%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 87.185547000845.ToString("F0")%
Shared 0.ToString("F0")%
None 12.814452999154991.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ALLIANCEBERNSTEIN L.P. holds $10,903,455,836 across 14 Drug Manufacturers - General names. ABBV ranks #4 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,427,764 | $4,072,524,494 | |
| 2 | JNJ |
Johnson & Johnson
|
6,948,656 | $1,698,529,472 | |
| 3 | MRK |
Merck & Co., Inc.
|
11,301,486 | $1,359,455,750 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
5,416,509 | $1,178,036,542 | |
| 5 | AZN |
Astrazeneca PLC
|
5,279,565 | $1,041,235,809 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,729,225 | $798,482,088 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,872,680 | $295,528,042 | |
| 8 | AMGN |
Amgen Inc
|
599,207 | $210,830,982 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,178,036,542 | 5,416,509 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,533,154,419 | 6,709,941 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,685,918,453 | 7,281,327 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,025,118,005 | 5,522,670 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $898,376,922 | 4,287,786 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $883,991,928 | 4,974,631 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $972,468,142 | 4,924,388 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $812,027,307 | 4,734,301 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $891,416,284 | 4,895,202 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $649,904,972 | 4,193,747 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $612,161,247 | 4,106,811 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $576,793,950 | 4,281,110 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $636,497,324 | 3,993,834 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $644,781,396 | 3,989,737 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $519,969,534 | 3,874,298 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $594,542,308 | 3,881,838 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $575,709,024 | 3,551,348 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $422,523,959 | 3,120,561 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $306,946,997 | 2,845,527 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $283,675,054 | 2,518,422 | Shares | Defined | 2021-07-30 | |
| 2021-03-31 | $295,587,454 | 2,731,357 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $324,758,256 | 3,030,875 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $256,210,735 | 2,925,114 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $287,501,573 | 2,928,311 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $198,341,541 | 2,603,249 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||